Smart Biosensors Market Research Report - Global Forecast till 2027

Global Smart Biosensors Market: Information by Product Type (Wearable Biosensors, Non-wearable Biosensors), Technology (Electrochemical Biosensors, Others), Application (Drug Discovery, Others), End User (Point-Of-Care & Others)—Global Forecast till 2027

ID: MRFR/HC/6331-HCR | February 2021 | Region: Global | 85 pages

Market Scenario

The Global Smart Biosensors Market accounted for USD 12000 million and expected to register 7.64% CAGR  during the forecast period (2018–2023)

Biosensors are analytical devices used for detection of chemical and biological substances in the human body. Smart biosensors are easy to use, simple, accurate and effective than traditional methods of analysis. Biosensors are becoming popular in developed countries. The increasing prevalence of diabetes in emerging economies, demand for advanced monitoring systems, and increasing awareness about advance biosensors are expected to drive the growth of the market. According to the report published by World Health Organization(WHO) in 2016, diabetes is a major healthcare concern in Brazil, and it affected more than 8.1% of the population, the prevalence of diabetes was more in females, and it affected more than 8.8% females in the country. Moreover, rising R&D spending and collaborative strategies adopted by the top players such as new product launches and collaborations for product development are contributing to the growth of the market.

The rising cost of biosensors and unfavorable reimbursement policies may hamper the growth of the market during the assessment period.

Segmentation


The global smart biosensors market has been segmented on the basis of product type, technology, application, and end user.


On the basis of product type, the market has been classified as wearable biosensors, non-wearable biosensors.


The technology segment has been divided into electrochemical biosensors, piezoelectric biosensors, optical biosensors, thermal biosensors, nanomechanical biosensors, and others. thermal biosensors segment is likely to be the fastest growing segment during the forecast period.


The market, by application, has been segmented into blood glucose testing, cholesterol testing, blood gas analysis, pregnancy testing, drug discovery, infectious disease testing, and others.


The end user segment has been divided into point-of-care, home diagnostics, research labs, security & biodefense, environmental monitoring, food & beverage industry, and others


The market has been segmented, by region, into the Americas, Europe, Asia-Pacific, and the Middle East & Africa. The smart biosensors market in the Americas has further been segmented into North America and South America, with the North American market divided into the US and Canada.


The European smart biosensors market has been segmented into Western Europe and Eastern Europe. Western Europe has further been classified as Germany, France, the UK, Italy, Spain, and the rest of Western Europe. 


The smart biosensors market in Asia-Pacific has been segmented into Japan, China, India, South Korea, Australia, and the rest of Asia-Pacific. The smart biosensors market in the Middle East & Africa has been segmented into the Middle East and Africa.


Regional Market Summary


Global Smart Biosensors Market Share, by Region, 2017 (%)


Global Smart Biosensors Market Share, by Region, 2017


Source: MRFR Analysis


The Americas are expected to hold the maximum share of global smart biosensors market owing to the rising prevalence of chronic disorders, favorable policies implemented by government and regulatory authorities, and adoption of highly advanced technology. According to the article published in 2016 by National Council on Aging, the prevalence of Chronic disorders in American regions is continuously increasing and about 80 percent of older adults have at least one chronic disease, and more than 68 percent were suffering from more than one chronic disorders.


The European market is likely to be the second-largest smart biosensors market. The market growth in this region can be attributed to the presence of well-established healthcare system in the region, government initiatives for controlling chronic disorders, and increase in the population suffering from cardiovascular disorders. According to the European Heart Network, cardiovascular disorders are responsible for 3.9 million deaths in the European Union which are 45% of the total deaths.


Asia-Pacific is expected to be the fastest-growing smart biosensors market during the forecast period owing to the increasing prevalence of diabetes, increasing disposable income, and government initiatives for the development of the healthcare sector. According to the International Diabetes Federation, in 2017, more than 84 million people in South-East Asia were affected by diabetes, and this number is expected to reach 156 million by 2045.


The market in the Middle East & Africa is expected to hold the smallest share of the global smart biosensors market due to an underdeveloped healthcare sector, lack of technical knowledge, and poor medical facilities.


Key Players


Some of the key players in the global smart biosensors market are Abbott Point of Care Inc., Medtronic Inc., F. Hoffman La-Roche Ltd., Siemens Healthcare AG, Lifescan, Inc., LifeSensors Inc., Nova Biomedical Corp., Acon Laboratories Inc., Universal Biosensors, Pharmaco-Kinesis Corporation, Biacore, and Others


Global Smart Biosensors Market, by Product Type



  •  Wearable Biosensors

  • Non-wearable Biosensors


Global Smart Biosensors Market, by Technology



  • Electrochemical Biosensors

  • Piezoelectric Biosensors

  • Optical Biosensors

  • Thermal Biosensors

  • Nanomechanical Biosensors

  • Others


Global Smart Biosensors Market, by Application



  • Blood Glucose Testing

  • Cholesterol Testing

  • Blood Gas Analysis

  • Pregnancy Testing

  • Drug Discovery

  • Infectious Disease Testing

  • Others


Global Smart Biosensors Market, by End User



  • Point-Of-Care

  • Home Diagnostics

  • Research Labs

  • Security & Biodefense

  • Environmental Monitoring

  • Food & Beverage Industry

  • Others


Global Smart Biosensors Market, by Region



  • Americas

    • North America

      • US

      • Canada



    • South America



  • Europe

    • Western Europe

      • Germany

      • France

      • Italy

      • Spain

      • UK

      • Rest of Western Europe



    • Eastern Europe



  • Asia-Pacific

    • Japan

    • China

    • India

    • Australia

    • South Korea

    • Rest of Asia-Pacific



  • Middle East & Africa

    • Middle East

    • Africa




Company Profiles 

  • Abbott Point of Care Inc.

  • Medtronic Inc.

  • Hoffman La-Roche Ltd.

  • Siemens Healthcare AG

  • Lifescan, Inc.

  • LifeSensors Inc.

  • Nova Biomedical Corp.

  • Acon Laboratories Inc.

  • Universal Biosensors

  • Pharmaco-Kinesis Corporation

  • Biacore


Intended Audience



  • Biosensor manufacturers

  • Biosensor distributors and suppliers

  • Healthcare providers

  • Medical device manufacturers

  • Research institutes and academic centers

  • Contract research organizations (CROs)

  • Government associations

  • Market research and consulting



Report Scope:
Report Attribute/Metric Details
  Market Size   USD 12000 Million
  CAGR   7.64%
  Base Year   2019
  Forecast Period   2027
  Historical Data   2018
  Forecast Units   Value (USD Million)
  Report Coverage   Revenue Forecast, Competitive Landscape, Growth Factors, and Trends
  Segments Covered   Product Type, Technology, Application, And End User
  Geographies Covered   North America, Europe, Asia-Pacific, and Rest of the World (RoW)
  Key Vendors   Abbott Point of Care Inc., Medtronic Inc., F. Hoffman La-Roche Ltd., Siemens Healthcare AG, Lifescan, Inc., LifeSensors Inc., Nova Biomedical Corp., Acon Laboratories Inc., Universal Biosensors, Pharmaco-Kinesis Corporation, Biacore, and Others
  Key Market Opportunities   R&D spending and collaborative strategies adopted by the top players such as new product launches and collaborations for product development
  Key Market Drivers

  • Increasing prevalence of diabetes in emerging economies
  • Demand for advanced monitoring systems
  • Increasing awareness about advance biosensors


  • Speak to Analyst Ask for Customization

    Frequently Asked Questions (FAQ) :


    Smart biosensors market is projected to grow at a 7.64% CAGR between 2018-2023.

    The Americas is expected to dominate the smart biosensors market.

    Smart biosensors market is predicted to touch USD 12000 million by 2023.

    Smart biosensors are widely used in drug discovery, blood glucose testing, pregnancy testing, and others.

    Unfavourable reimbursement policies and increasing cost of biosensors may limit the smart biosensors market growth.

    Table of Contents:

    Chapter 1. Report Prologue

    Chapter 2. Market Introduction

    2.1 Definition

    2.2 Scope of the Study

    2.2.1 Research Objective

    2.2.2 Assumptions

    2.2.3 Limitations

    Chapter 3. Research Methodology

    3.1 Introduction

    3.2 Primary Research

    3.3 Secondary Research

    3.4 Market Size Estimation

    Chapter 4. Market Dynamics

    4.1 Drivers

    4.2 Restraints

    4.3 Opportunities

    4.4 Challenges

    4.5 Macroeconomic Indicators

    4.6 Technology Trends & Assessment

    Chapter 5. Market Factor Analysis

    5.1 Porter’s Five Forces Analysis

    5.1.1 Bargaining Power of Suppliers

    5.1.2 Bargaining Power of Buyers

    5.1.3 Threat of New Entrants

    5.1.4 Threat of Substitutes

    5.1.5 Intensity of Rivalry

    5.2 Value Chain Analysis

    5.3 Investment Feasibility Analysis

    5.4 Pricing Analysis

    Chapter 6. Global Smart Biosensors Market, by Product Type

    6.1 Introduction

    6.2 Wearable Biosensors

    Market Estimates & Forecast, by Region, 2020–2027

    Market Estimates & Forecast, by Country, 2020–2027

    6.3 Non-wearable Biosensors

    Market Estimates & Forecast, by Region, 2020–2027

    Market Estimates & Forecast, by Country, 2020–2027

    Chapter 7. Global Smart Biosensors Market, by Technology

    7.1 Introduction

    7.2 Electrochemical Biosensors

    Market Estimates & Forecast, by Region, 2020–2027

    Market Estimates & Forecast, by Country, 2020–2027

    7.3 Piezoelectric Biosensors

    Market Estimates & Forecast, by Region, 2020–2027

    Market Estimates & Forecast, by Country, 2020–2027

    7.4 Optical Biosensors

    Market Estimates & Forecast, by Region, 2020–2027

    Market Estimates & Forecast, by Country, 2020–2027

    7.5 Thermal Biosensors

    Market Estimates & Forecast, by Region, 2020–2027

    Market Estimates & Forecast, by Country, 2020–2027

    7.6 Nanomechanical Biosensors

    Market Estimates & Forecast, by Region, 2020–2027

    Market Estimates & Forecast, by Country, 2020–2027

    7.7 Others

    Chapter 8. Global Smart Biosensors Market, by Application

    8.1 Introduction

    8.2 Blood Glucose Testing

    Market Estimates & Forecast, by Region, 2020–2027

    Market Estimates & Forecast, by Country, 2020–2027

    8.3 Cholesterol Testing

    Market Estimates & Forecast, by Region, 2020–2027

    Market Estimates & Forecast, by Country, 2020–2027

    8.4 Blood Gas Analysis

    Market Estimates & Forecast, by Region, 2020–2027

    Market Estimates & Forecast, by Country, 2020–2027

    8.5 Pregnancy Testing

    Market Estimates & Forecast, by Region, 2020–2027

    Market Estimates & Forecast, by Country, 2020–2027

    8.6 Drug Discovery

    Market Estimates & Forecast, by Region, 2020–2027

    Market Estimates & Forecast, by Country, 2020–2027

    8.7 Infectious Disease Testing

    Market Estimates & Forecast, by Region, 2020–2027

    Market Estimates & Forecast, by Country, 2020–2027

    8.8 Others

    Chapter 9. Global Smart Biosensors Market, by End User

    9.1 Introduction

    9.2 Point-Of-Care

    Market Estimates & Forecast, by Region, 2020–2027

    Market Estimates & Forecast, by Country, 2020–2027

    9.3 Home Diagnostics

    Market Estimates & Forecast, by Region, 2020–2027

    Market Estimates & Forecast, by Country, 2020–2027

    9.4 Research Labs

    Market Estimates & Forecast, by Region, 2020–2027

    Market Estimates & Forecast, by Country, 2020–2027

    9.5 Security & Biodefense

    Market Estimates & Forecast, by Region, 2020–2027

    Market Estimates & Forecast, by Country, 2020–2027

    9.6 Environmental Monitoring

    Market Estimates & Forecast, by Region, 2020–2027

    Market Estimates & Forecast, by Country, 2020–2027

    9.7 Food & Beverage Industry

    Market Estimates & Forecast, by Region, 2020–2027

    Market Estimates & Forecast, by Country, 2020–2027

    9.9 Others

    Chapter 10. Global Smart Biosensors Market, by Region

    10.1 Introduction

    10.2 Americas

    10.2.1 North America

    10.2.1.1 US

    10.2.1.2 Canada

    10.2.2 South America

    10.3 Europe

    10.3.1 Western Europe

    10.3.1.1 Germany

    10.3.1.2 France

    10.3.1.3 Italy

    10.3.1.4 Spain

    10.3.1.5 UK

    10.3.1.6 Rest of Western Europe

    10.3.2 Eastern Europe

    10.4 Asia-Pacific

    10.4.1 Japan

    10.4.2 China

    10.4.3 India

    10.4.4 Australia

    10.4.5 South Korea

    10.4.6 Rest of Asia-Pacific

    10.5 Middle East & Africa

    10.5.1 Middle East

    10.5.2 Africa

    Chapter 11. Company Landscape

    11.1 Introduction

    11.2 Market Share Analysis

    11.3 Key Development & Strategies

    Chapter 12. Company Profiles

    12.1 Abbott Point of Care Inc.

    12.1.1 Company Overview

    12.1.2 Product Overview

    12.1.3 Financials Overview

    12.1.4 Key Developments

    12.1.5 SWOT Analysis

    12.2 Medtronic

    12.2.1 Company Overview

    12.2.2 Product Overview

    12.2.3 Financial Overview

    12.2.4 Key Developments

    12.2.5 SWOT Analysis

    12.3 F. Hoffman La-Roche Ltd

    12.3.1 Company Overview

    12.3.2 Product Overview

    12.3.3 Financial Overview

    12.3.4 Key Development

    12.3.5 SWOT Analysis

    12.4 Siemens Healthcare AG

    12.4.1 Company Overview

    12.4.2 Technology/Business Segment Overview

    12.4.3 Financial Overview

    12.4.4 Key Development

    12.4.5 SWOT Analysis

    12.5 Lifescan, Inc.

    12.5.1 Company Overview

    12.5.2 Product Overview

    12.5.3 Financial overview

    12.5.4 Key Developments

    12.5.5 SWOT Analysis

    12.6 LifeSensors Inc.

    12.6.1 Company Overview

    12.6.2 Product Overview

    12.6.3 Financial Overview

    12.6.4 Key Developments

    12.6.5 SWOT Analysis

    12.7 Nova Biomedical Corp.

    12.7.1 Overview

    12.7.2 Product Overview

    12.7.3 Financial Overview

    12.7.4 Key Developments

    12.7.5 SWOT Analysis

    12.8 Acon Laboratories Inc.

    12.8.1 Overview

    12.8.2 Product/ Technology Overview

    12.8.3 Financials

    12.8.4 Key Developments

    12.8.5 SWOT Analysis

    12.9 Universal Biosensors

    12.9.1 Overview

    12.9.2 Product Overview

    12.9.3 Financials

    12.9.4 Key Developments

    12.9.5 SWOT Analysis

    12.10 Pharmaco-Kinesis Corporation

    12.10.1 Overview

    12.10.2 Product Overview

    12.10.3 Financials

    12.10.4 Key Developments

    12.10.5 SWOT Analysis

    12.11 Biacore

    12.11.1 Overview

    12.11.2 Product Overview

    12.11.3 Financials

    12.11.4 Key Developments

    12.11.5 SWOT Analysis

    11.12 Others

    Chapter 12 MRFR Conclusion

    12.1 Key Findings

    12.1.1 From CEO’s Viewpoint

    12.1.2 Unmet Needs of the Market

    12.2 Key Companies to Watch

    12.3 Predictions for the Smart Biosensors Industry

    Chapter 13. Appendix

    LIST OF TABLES

    Table 1 Global Smart Biosensors Market Synopsis, 2020–2027

    Table 2 Global Smart Biosensors Market Estimates and Forecast, 2020–2027 (USD Million)

    Table 3 Global Smart Biosensors Market, by Region, 2020–2027 (USD Million)

    Table 4 Global Smart Biosensors Market, by Product Type, 2020–2027 (USD Million)

    Table 5 Global Smart Biosensors Market, by Technology, 2020–2027 (USD Million)

    Table 6 Global Smart Biosensors Market, by Application, 2020–2027 (USD Million)

    Table 7 Global Smart Biosensors Market, by End User, 2020–2027 (USD Million)

    Table 8 North America: Smart Biosensors Market, by Product Type, 2020–2027 (USD

    Million)

    Table 9 North America: Smart Biosensors Market, by Technology, 2020–2027 (USD

    Million)

    Table 10 North America: Smart Biosensors Market, by Application, 2020–2027 (USD

    Million)

    Table 11 North America: Smart Biosensors Market, by End User, 2020–2027 (USD

    Million)

    Table 12 US: Smart Biosensors Market, by Product Type, 2020–2027 (USD Million)

    Table 13 US: Smart Biosensors Market, by Technology, 2020–2027 (USD Million)

    Table 14 US: Smart Biosensors Market, by Application, 2020–2027 (USD Million)

    Table 15 US: Smart Biosensors Market, by End User, 2020–2027 (USD Million)

    Table 16 Canada: Smart Biosensors Market, by Product Type, 2020–2027 (USD Million)

    Table 17 Canada: Smart Biosensors Market, by Technology, 2020–2027 (USD Million)

    Table 18 Canada: Smart Biosensors Market, by Application, 2020–2027 (USD

    Million)

    Table 19 Canada: Smart Biosensors Market, by End User, 2020–2027 (USD

    Million)

    Table 20 South America: Smart Biosensors Market, by Product Type, 2020–2027 (USD

    Million)

    Table 21 South America: Smart Biosensors Market, by Technology, 2020–2027 (USD

    Million)

    Table 22 South America: Smart Biosensors Market, by Application, 2020–2027 (USD

    Million)

    Table 23 South America: Smart Biosensors Market, by End User, 2020–2027 (USD

    Million)

    Table 24 Europe: Smart Biosensors Market, by Product Type, 2020–2027 (USD Million)

    Table 25 Europe: Smart Biosensors Market, by Technology, 2020–2027 (USD Million)

    Table 26 Europe: Smart Biosensors Market, by Application, 2020–2027 (USD Million)

    Table 27 Europe: Smart Biosensors Market, by End User, 2020–2027 (USD Million)

    Table 28 Western Europe: Smart Biosensors Market, by Product Type, 2020–2027 (USD

    Million)

    Table 29 Western Europe: Smart Biosensors Market, by Technology, 2020–2027 (USD

    Million)

    Table 30 Western Europe: Smart Biosensors Market, by Application, 2020–2027

    (USD Million)

    Table 31 Western Europe: Smart Biosensors Market, by End User, 2020–2027

    (USD Million)

    Table 32 Eastern Europe: Smart Biosensors Market, by Product Type, 2020–2027 (USD

    Million)

    Table 33 Eastern Europe: Smart Biosensors Market, by Technology, 2020–2027 (USD

    Million)

    Table 34 Eastern Europe: Smart Biosensors Market, by Application, 2020–2027

    (USD Million)

    Table 35 Eastern Europe: Smart Biosensors Market, by End User, 2020–2027

    (USD Million)

    Table 36 Asia-Pacific: Smart Biosensors Market, by Product Type, 2020–2027 (USD

    Million)

    Table 37 Asia-Pacific: Smart Biosensors Market, by Technology, 2020–2027 (USD

    Million)

    Table 38 Asia-Pacific: Smart Biosensors Market, by Application, 2020–2027 (USD

    Million)

    Table 39 Asia-Pacific: Smart Biosensors Market, by End User, 2020–2027 (USD

    Million)

    Table 40 Middle East & Africa: Smart Biosensors Market, by Product Type, 2020–2027

    (USD Million)

    Table 41 Middle East & Africa: Smart Biosensors Market, by Technology, 2020–2027

    (USD Million)

    Table 42 Middle East & Africa: Smart Biosensors Market, by Application, 2020–2027

    (USD Million)

    Table 43 Middle East & Africa: Smart Biosensors Market, by End User, 2020–2027

    (USD Million)

    LIST OF FIGURES

    Figure 1 Research Process

    Figure 2 Segmentation for Global Smart Biosensors Market

    Figure 3 Segmentation Market Dynamics for Global Smart Biosensors Market

    Figure 4 Global Smart Biosensors Market Share, by Product Type, 2020

    Figure 5 Global Smart Biosensors Market Share, by Technology, 2020

    Figure 6 Global Smart Biosensors Market Share, by Application, 2020

    Figure 7 Global Smart Biosensors Market Share, by End User, 2020

    Figure 8 Global Smart Biosensors Market Share, by Region, 2020

    Figure 9 North America: Smart Biosensors Market Share, by Country, 2020

    Figure 10 Europe: Smart Biosensors Market Share, by Country, 2020

    Figure 11 Asia-Pacific: Smart Biosensors Market Share, by Country, 2020

    Figure 12 Middle East & Africa: Smart Biosensors Market Share, by Country, 2020

    Figure 13 Global Smart Biosensors Market: Company Share Analysis, 2020 (%)

    Figure 14 Abbott Point of Care Inc.: Key Financials

    Figure 15 Abbott Point of Care Inc.: Segmental Revenue

    Figure 16 Abbott Point of Care Inc.: Geographical Revenue

    Figure 17 Medtronic: Key Financials

    Figure 18 Medtronic: Segmental Revenue

    Figure 19 Medtronic: Geographical Revenue

    Figure 20 F. Hoffman La-Roche Ltd.: Key Financials

    Figure 21 F. Hoffman La-Roche Ltd.: Segmental Revenue

    Figure 22 F. Hoffman La-Roche Ltd.: Geographical Revenue

    Figure 23 Siemens Healthcare AG: Key Financials

    Figure 24 Siemens Healthcare AG: Segmental Revenue

    Figure 25 Siemens Healthcare AG: Geographical Revenue

    Figure 26 Lifescan, Inc.: Key Financials

    Figure 27 Lifescan, Inc.: Segmental Revenue

    Figure 28 Lifescan, Inc. Geographical Revenue

    Figure 29 LifeSensors Inc.: Key Financials

    Figure 30 LifeSensors Inc.: Segmental Revenue

    Figure 31 LifeSensors Inc.: Geographical Revenue

    Figure 32 Nova Biomedical Corp.: Key Financials

    Figure 33 Nova Biomedical Corp.: Segmental Revenue

    Figure 34 Nova Biomedical Corp.: Geographical Revenue

    Figure 35 Acon Laboratories Inc.: Key Financials

    Figure 36 Acon Laboratories Inc.: Segmental Revenue

    Figure 37 Acon Laboratories Inc.: Geographical Revenue

    Figure 38 Universal Biosensors: Key Financials

    Figure 39 Universal Biosensors: Segmental Revenue

    Figure 40 Universal Biosensors: Geographical Revenue

    Figure 41 Pharmaco-Kinesis Corporation: Key Financials

    Figure 42 Pharmaco-Kinesis Corporation: Segmental Revenue

    Figure 43 Pharmaco-Kinesis Corporation: Geographical Revenue

    Figure 45 Biacore: Segmental Revenue

    Figure 46 Biacore: Geographical Revenue

    Figure 47 Biacore Corporation: Key Financials



    This table of content is tentative and subject to change as the research progresses.

    Please Note:  Financial details of company cannot be provided if the information of the company is not available in public domain and or reliable source.